A B S T R A C T Studies from our laboratory have shown that the metabolic clearance rate of carboxy terminal immunoreactive parathyroid hormone (i-PTH) can be accounted for by extraction ofi-PTH by liver and kidney. In contrast, there was no demonstrable hepatic uptake of the synthetic amino terminal bovine PTH fragment and the kidney accounted for only 45% of the metabolic clearance rate of amino terminal i-PTH. This suggested that another major site, presumably bone, played a role in the metabolism of syn b-PTH 1-34. Extraction of i-PTH by isolated perfused bone was studied during infusion of purified bovine PTH (b-PTH) 1-84 or syn b-PTH 1-34. In five studies during infusion of syn b-PTH 1-34 the arteriovenous difference for i-PTH across bone was 36%. In contrast, no significant uptake of carboxy terminal i-PTH was observed in nine studies during infusion of b-PTH 1-84. In addition, when H202-oxidized (biologically inactive) syn b-PTH 1-34 was used no arteriovenous difference was observed. These findings correlated with the ability of these PTH preparations to stimulate cyclic AMP production by the perfused bone. Syn b-PTH 1-34 increased cyclic AMP production at perfusate PTH concentrations of 1-5 ng/ml, whereas b-PTH 1-84 evoked only a minimal response at concentrations of 10-20 ng/ml. We conclude that bone is a major site of metabolism of the amino terminal PTH fragment, syn b-PTH 1-34. In addition, these data suggest that cleavage of the intact hormone, with the production ofamino terminal PTH fragments by peripheral
INTRODUCTION
Circulating immunoreactive parathyroid hormone (PTH)' exists as a mixture of the intact hormone and its fragments (1) (2) (3) (4) . Although there is evidence that PTH fragments may be secreted to some extent directly by the parathyroid glands (5) (6) (7) , metabolism of intact PTH by peripheral organs undoubtedly contributes to the immunoheterogenous nature of circulating PTH.
Previous studies from our laboratory have shown that after injection of bovine PTH (b-PTH to dogs, the kidney accounts for -60% of the total metabolic clearance rate of carboxy terminal immunoreactive PTH (8) . The remaining 40%, therefore, is a result of PTH uptake at extrarenal sites. In studies designed to investigate the extrarenal sites of PTH metabolism, we have shown that the liver is an important site of PTH degradation (9) . Hepatic uptake of immunoreactive PTH (i-PTH) is selective for the intact hormone and this organ does not remove carboxy terminal PTH fragments from the circulation. The hepatic uptake of intact PTH, however, appears to account completely for the extrarenal clearance of carboxy terminal i-PTH.
In studies using the synthetic amino terminal b-PTH fragment (syn b-PTH 1-34) significant differences were apparent between hepatic and renal PTH uptake. The kidney accounted for 45% of the metabolic clearance rate of amino terminal i-PTH, leaving the major portion (55%) to be accounted for by extrarenal sites. How- ' Abbreviations used in this paper: A-V, arterio-venous; b-PTH, bovine PTH; cAMP, cyclic AMP; i-PTH, immunoreactive PTH; PTH, parathyroid hormone; syn b-PTH 1-34, synthetic amino terminal bovine PTH fragment. ever, our previous studies did not demonstrate ainy uiptake of this amino terminal i-PTH fragment by the liver (9).
Parsons and Robinson (10) provided evidenee for mobilization of calcium from bone after intravenous injection of intact b-PTH 1-84 to an anesthetized cat whose tibia vwas l)eing perfufsed with its own arterial blood, but no calcium was mol)ilized when the hormone was added directly to their perfusing blood so that it did not enter the intact animal. These observations suggest that intact b-PTH 1-84 must undergo some alteration in the whole animal before it is capable of exerting its effect on bone. The present studies were designed to examine the possibility that bone might represent the maijor extrarenal site of metabolism of the syn b-PTH 1-34. Recirculating studies. The possibility that the minimal increase in cAMP seen with b-PTH 1-84 was a result of cleavage of the intact hormone resulting in the production of an amino terminal fragment was assessed by analysis of perfusate which was allowed to recirculate for periods as long as 2 h. Portions of perfusate were analyzed by polyacrylamide gel electrophoresis and eluates of the gel slices assayed using carboxy and amino terminal specific antisera. No signifiant degradation of b-PTH 1-84 to carboxy and(or) amino terminal fragments was apparent.
DISCUSSION
The immunoheterogenous nature of circulating parathyroid hormone is well recognized (1-4) . However, controversy continues as to the major source of circulating PTH fragments. Although there is evidence that the parathyroid glands are a source at least of carboxy terminal PTH fragments, there is considerable evidence for a role of peripheral organs in the generation of these PTH fragments. Previous studies from our laboratory have shown that after injection of intact b-PTH 1-84 to dogs, the pattern of circulating i-PTH changes from intact hormone to a mixture of carboxy and amino terminal fragments and finally to carboxy terminal fragments alone (8, 9) . Studies using the isolated perfused liver of the rat (14) and the isolated perfused canine kidney (15) have shown extensive degradation of intact b-PTH 1-84 by these organs. Furthermore, these studies demonstrated that the rate of PTH degradation in liver and kidney was modulated by perfusate calcium concentration. Elevated perfusate calcium concentration impaired the metabolism of the intact hormone to carboxy and amino terminal fragments, whereas the production of PTH fragments was accelerated in the presence of low perfusate calcium concentrations. However, the overall physiological significance of the peripheral metabolism of intact PTH remains obscure. Is the peripheral degradation of intact PTH necessary for the expression of its biological effect or is the formnation of fragments a consequence of the biological action of the intact hormone? Studies in vitro with bovine and canine renal cortical membranes have shown that the intact hormone can exert a biological effect per se in the absence of degradation (16), although other investigators have shown extensive degradation of intact PTH by renal cortical membranes of the rat (17) . Previous studies from our laboratory have shown interesting differences in the uptake of PTH by liver and kidney (9) . The canine liver demonstrates a selective uptake of the intact hormone but does not remove carboxy or amino terminal PTH fragments from the circulation, whereas the kidney removes 1)oth the intact hormone and its fragments from the circulation. The renal uptake of biologically active forms of PTH, namely, the intact hormone and the syn b-PTH 1-34, occurs mainly at peritubular sites, whereas the renal removal of biologically inactive PTH fragments depends exclusively on the process of glomerular filtration and tubular reabsorption (18) .
The present studies demonstrate that uptake of PTH by the other major target organ for PTH, i.e. bone, differs from the uptake observed in both liver and kidney. In bone, a marked A-V difference for the syn b-PTH 1-34 is apparent, whereas no significant uptake of b-PTH 1-84 could be demonstrated. These uptake data correlate well with the biological effect of PTH in stimulating cAMP production. syn-b-PTH 1-34 clearly induced a marked increase in cAMP production by the perfused bone at concentrations as low as 1-ng/ml of perfusate. Intact b-PTH 1-84 produced only a minimal increase in cAMP production even at concentrations as high as 20 ng/ml.
The present findings are consistent with the observations of Parsons and Robinson (10) Although it may be argued that metabolism of b-PTH 1-84 by bone yields fragments that are not immunoreactive in our assays, this possibility is unlikely because the intact hormone peak did not change significantly. These data are in contrast to previous findings in fetal rat calvaria in which intact b-PTH 1-84 readily stimulates cAMP production (19, 20) . However, b-PTH 1-84 is extensively degraded to PTH fragments by fetal bone cells whereas oxidized b-PTH 1-84, devoid of biological activity is not metabolized (20) . Thus, degradation of b-PTH 1-84 appears to be related to expression of biological activity in fetal rat calvarial preparations. Our failure to demonstrate degradation of intact b-PTH 1-84 in the present studies may represent a difference between adult and fetal bone, a species difference, or differences in experimental design. Fig. 4 illustrates our proposed scheme for the peripheral metabolism of PTH. PTH is secreted from the parathyroid glands predominantly in the intact form and undergoes metabolism by the liver and kidney resulting in the production ofcarboxy and amino terminal fragments. The carboxy terminal fragments are further metabolized by the kidney by glomerular filtration and tubular reabsorption. The amino terminal fragments, in addition to intact PTH, may act on the peritubular side of the renal tubular cells and mediate the biological effect of PTH on the kidney. The present studies suggest that peripheral metabolism of intact 
